Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

21.35
Delayed Data
As of Aug 25
 -0.51 / -2.33%
Today’s Change
9.51
Today|||52-Week Range
24.00
+58.85%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues1.5M12.0M122.0M144.4M
 
 
 
 
 
Cost of Goods Sold--362.0K4.8M7.5M
 
 
 
 
Depreciation And Amortization871.0K742.0K928.0K921.0K
 
 
 
 
 
 
Operating ExpensesGross Income--10.9M116.3M136.0M
 
 
 
 
General Expenses42.8M72.8M92.1M118.3M
 
 
 
 
 
Research And Development23.5M17.2M19.6M29.1M
 
 
 
 
 
Total Operating Expenses43.6M73.9M97.8M126.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-42.2M-61.9M24.2M17.7M
 
 
 
 
 
Extraordinary Credit0.000.002.8M193.0K
 
 
 
Extraordinary Charge0.00-22.9M-2.6M-2.3M
 
 
 
 
Interest Expense On Debt3.6M7.8M5.0M1.2M
 
 
 
 
 
Other Expenses-660.0K101.0K39.0K38.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-46.3M-92.3M19.9M15.0M
 
 
 
 
 
Income Taxes0.000.000.00-956.0K
 
 
Preferred Dividend-1.1M0.000.000.00
 
 
Net Income-46.3M-92.3M19.9M14.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS17.4M31.8M42.3M47.5M
 
 
 
 
 
Shares To Calculate EPS Diluted17.4M31.8M50.6M51.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.72-$2.90$0.32$0.28
 
 
 
 
 
EPS Diluted-$2.72-$2.90$0.32$0.28